Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
House Collapses Into River in Alaska
City officials in Juneau issued an emergency declaration earlier this week as a glacial break caused major flooding that led to the collapse of a house in a river.
Load More